Evidence map›Paper›PMID 35258738›Full record

ReviewEnvironmental science and pollution research international2022

Critical role of nitric oxide in impeding COVID-19 transmission and prevention: a promising possibility.

Rajalakshmi Rajendran, Anjana Chathambath, Abdullah G Al-Sehemi, Mehboobali Pannipara, Mazhuvancherry Kesavan Unnikrishnan, Lotfi Aleya, Roshni Pushpa Raghavan, Bijo Mathew

Open access · bronzeAbstract readReview
In one paragraph

Review in Environmental science and pollution research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Therapeutic Gases in Biomedicine: Updates on Nitric Oxide and Beyond.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Article
  3. Oral SARS-CoV-2 Infection and Risk for Long Covid.Reviews in medical virology · 2025
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Rajalakshmi RajendranDepartment of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, 682041, Kerala, India.
Anjana ChathambathDepartment of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, 682041, Kerala, India.
Abdullah G Al-SehemiResearch Center for Advanced Materials Science, King Khalid University, Abha, 61413, Saudi Arabia.
Mehboobali PanniparaResearch Center for Advanced Materials Science, King Khalid University, Abha, 61413, Saudi Arabia.
Mazhuvancherry Kesavan UnnikrishnanNGSM Institute of Pharmaceutical Sciences, Nitte Deemed To Be University, Manglore, 575018, India.
Lotfi AleyaLaboratoire Chrono-Environment, Universite de Bourgogne Franche-Comte, CNRS6249, Besancon, France.
Roshni Pushpa RaghavanDepartment of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, 682041, Kerala, India. roshnipr@aims.amrita.edu.
Bijo MathewDepartment of Pharmaceutical Chemistry, Amrita School of Pharmacy, AIMS Health Sciences Campus, Amrita Vishwa Vidyapeetham, Kochi, 682 041, India.ORCID http://orcid.org/0000-0002-6658-4497
Amrita Vishwa Vidyapeetham · INKing Khalid University · SACentre National de la Recherche Scientifique · FRNitte University · IN

Funding

King Khalid University 3-N-20/21
6 · The paper itself

Abstract

COVID-19 is a serious respiratory infection caused by a beta-coronavirus that is closely linked to SARS. Hypoxemia is a symptom of infection, which is accompanied by acute respiratory distress syndrome (ARDS). Augmenting supplementary oxygen may not always improve oxygen saturation; reversing hypoxemia in COVID-19 necessitates sophisticated means to promote oxygen transfer from alveoli to blood. Inhaled nitric oxide (iNO) has been shown to inhibit the multiplication of the respiratory coronavirus, a property that distinguishes it from other vasodilators. These findings imply that NO may have a crucial role in the therapy of COVID-19, indicating research into optimal methods to restore pulmonary physiology. According to clinical and experimental data, NO is a selective vasodilator proven to restore oxygenation by helping to normalize shunts and ventilation/perfusion mismatches. This study examines the role of NO in COVID-19 in terms of its specific physiological and biochemical properties, as well as the possibility of using inhaled NO as a standard therapy. We have also discussed how NO could be used to prevent and cure COVID-19, in addition to the limitations of NO.

Indexed as

COVID-19Administration, InhalationHumansHypoxiaNitric OxideOxygenNitric OxideOxygenCOVID-19Mechanical ventilationNitric oxideSARS CoV-2Vasodilation

Identifiers

PMID35258738
PMCPMC8902850
OpenAlexW4220836343

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.